pubmed-article:18024865 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18024865 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
pubmed-article:18024865 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18024865 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:18024865 | lifeskim:mentions | umls-concept:C0442034 | lld:lifeskim |
pubmed-article:18024865 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
pubmed-article:18024865 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:18024865 | lifeskim:mentions | umls-concept:C0440743 | lld:lifeskim |
pubmed-article:18024865 | pubmed:issue | 33 | lld:pubmed |
pubmed-article:18024865 | pubmed:dateCreated | 2007-11-20 | lld:pubmed |
pubmed-article:18024865 | pubmed:abstractText | We evaluated the efficacy and safety of bevacizumab in patients with platinum-resistant epithelial ovarian carcinoma (EOC) or peritoneal serous carcinoma (PSC) who had experienced disease progression during, or within 3 months of discontinuing, topotecan or liposomal doxorubicin. | lld:pubmed |
pubmed-article:18024865 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:language | eng | lld:pubmed |
pubmed-article:18024865 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18024865 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18024865 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18024865 | pubmed:month | Nov | lld:pubmed |
pubmed-article:18024865 | pubmed:issn | 1527-7755 | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:DouglasJeffre... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:McGuireWillia... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:BurgerRobert... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:CannistraStep... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:PensonRichard... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:HambletonJuli... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:ArmstrongDebo... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:DupontJakobJ | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:MatulonisUrsu... | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:MackeyHowardH | lld:pubmed |
pubmed-article:18024865 | pubmed:author | pubmed-author:WenhamRobertR | lld:pubmed |
pubmed-article:18024865 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18024865 | pubmed:day | 20 | lld:pubmed |
pubmed-article:18024865 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:18024865 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18024865 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18024865 | pubmed:pagination | 5180-6 | lld:pubmed |
pubmed-article:18024865 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:meshHeading | pubmed-meshheading:18024865... | lld:pubmed |
pubmed-article:18024865 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:18024865 | pubmed:articleTitle | Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. | lld:pubmed |
pubmed-article:18024865 | pubmed:affiliation | Beth Israel Deaconess Medical Center, East Campus KS158, 330 Brookline Ave, Boston, MA 02215, USA. scannist@bidmc.harvard.edu | lld:pubmed |
pubmed-article:18024865 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18024865 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:18024865 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18024865 | lld:pubmed |